Sonoma files investor presentation; no new material details visible in exhibit text

Sonoma Pharmaceuticals, Inc.

Furnished investor presentation under Item 7.01 for virtual conferences on Jan 10-13, 2022.
Presentation text provided in filing is truncated and contains only standard disclaimers.
No specific financial results, guidance, or business updates can be extracted from available text.
Filing does not contain any earnings release, M&A, leadership change, or other material event.
Investors should refer to the full presentation if made available elsewhere for potential updates.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.